Search Results 7631-7640 of 33577 for oral

  1. Heart Failure Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine the effect of a single dose of an oral acute MPO inhibitor drug on resting and exercise hemodynamics (arterial ...

  2. Throat cancer - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...

  3. Research - Mayo Clinic News Network

    January 21, 2026. New CT imaging oral contrast agent ...

  4. Publications - Matthew M. Melin, M.D. - Mayo Clinic

    Epub 2022 Mar 29. View PubMed; Zwart SR, Aunon-Chancellor SM, Heer M, Melin MM, Smith SM. Albumin, oral contraceptives, and venous thromboembolism risk in ...

  5. Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1) - Mayo Clinic

    ... oral or parenteral corticosteroids * Active, chronic disease of the immune system (including stable disease treated with immune therapy (e.g. Leflunomide ...

  6. Statins for the Treatment of NASH - Mayo Clinic

    Pregnancy or breastfeeding. 20. Women, of childbearing age, who are not willing to practice effective contraception (i.e., barrier, oral contraceptives, or ...

  7. Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis - Mayo Clinic

    The purpose of this study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral dose of ...

  8. A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS) - Mayo Clinic

    ... oral ketoconazole, chemotherapy, immunotherapy, estrogens, radiopharmaceuticals. 9. History of prior pelvic radiation therapy 10. Concurrent treatment with ...

  9. VE303 for Prevention of Recurrent Clostridioides Difficile Infection - Mayo Clinic

    ... oral or parenteral antibacterial therapy for a non-CDI indication after randomization. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

  10. Publications - Alyssa M. Larish, M.D. - Mayo Clinic

    Oral Oncol. 2023 Nov; 146:106568 Epub 2023 Sept 16. View PubMed; Dinoi G, Multinu F, Yost K, AlHilli M, Larish A, Langstraat C, Kumar A, Weaver AL, McGree M ...